Petra Financial Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$408K Buy
3,943
+178
+5% +$15.9K 0.19% 117
2026
Q1
$270K Sell
3,765
-474
-11% -$36.5K 0.17% 105
2025
Q4
$336K Sell
4,239
-315
-7% -$24.8K 0.2% 114
2025
Q3
$343K Buy
4,554
+63
+1% +$4.32K 0.2% 113
2025
Q2
$310K Buy
4,491
+143
+3% +$9.38K 0.2% 114
2025
Q1
$295K Buy
+4,348
New +$260K 0.24% 90
2024
Q4
Sell
-4,145
Closed -$261K 146
2024
Q3
$261K Sell
4,145
-236
-5% -$13.8K 0.17% 118
2024
Q2
$259K Sell
4,381
-201
-4% -$12.6K 0.19% 109
2024
Q1
$365K Buy
4,582
+215
+5% +$16.4K 0.27% 90
2023
Q4
$345K Sell
4,367
-1,127
-21% -$80.2K 0.29% 86
2023
Q3
$384K Buy
5,494
+355
+7% +$25.2K 0.32% 84
2023
Q2
$355K Sell
5,139
-363
-7% -$25.8K 0.32% 81
2023
Q1
$409K Buy
5,502
+363
+7% +$30.4K 0.4% 47
2022
Q4
$479K Buy
+5,139
New +$496K 0.53% 49

Other funds holding CVS

Petra Financial Advisors's CVS Position: Q2 2026 in Review

Petra Financial Advisors increased its CVS Health (CVS) stake by 4.7% in Q2 2026, buying an estimated $15.9K and bringing the position to 3,943 shares worth $408K. The position accounts for 0.19% of the portfolio, ranked #117.

Petra Financial Advisors first reported a position in CVS in Q4 2022 and has held it in 14 quarters since. The position peaked at $479K in Q4 2022. 2,068 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Petra Financial Advisors held 3,943 shares of CVS Health worth $408K as of Q2 2026.
  • Petra Financial Advisors bought 178 CVS Health shares in Q2 2026, an estimated $15.9K.
  • CVS Health made up 0.19% of Petra Financial Advisors's portfolio in Q2 2026, its #117 holding.
  • Petra Financial Advisors first reported a position in CVS Health in Q4 2022 and has held it in 14 quarters since.
  • Petra Financial Advisors's CVS Health position peaked at $479K in Q4 2022.
  • 2,068 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Petra Financial Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.